Listen Now

Topics Covered

  • Overview of Diffuse Large B-Cell Lymphoma, in the Context of COVID-19
  • Staging and Grading
  • Current Standard of Care
  • Treatment Options for Resistant Disease
  • Emerging Treatment Approaches
  • The Role of Clinical Trials
  • How Research Contributes to Treatment Choices
  • Tips to Manage Side Effects
  • The Role of Telehealth/Telemedicine Appointments in Reducing Your Exposure to COVID-19
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments
  • Key Questions to Ask Your Health Care Team
  • Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts

David J. Straus, MD

Attending Physician, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Clinical Medicine, Weill Cornell Medical College

Sarah C. Rutherford, MD

John P. Leonard, MD/Gwirtzman Family Research Scholar in Lymphoma, Assistant Professor of Medicine, Weill Cornell Medical College, Cornell University

Adolfo Enrique Diaz, MD, MSc

Assistant Professor, Department of Medicine, Division of Hematology-Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center

Catherine S M Diefenbach, MD

Associate Professor of Medicine, Translational Director Hematology/Director Clinical Lymphoma, Perlmutter Cancer Center, An NCI-designated Comprehensive Cancer Center, NYU Langone Health

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(74.6 KB)

Workshop Date

This workshop was originally recorded on November 18, 2020.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.